Serial Number 98191524
Registration 7804692
700

Registration Progress

Application Filed
Sep 21, 2023
Under Examination
May 14, 2024
Approved for Publication
Feb 28, 2024
Published for Opposition
Mar 19, 2024
Registered
May 20, 2025

Trademark Image

Basic Information

Serial Number
98191524
Registration Number
7804692
Filing Date
September 21, 2023
Registration Date
May 20, 2025
Published for Opposition
March 19, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
May 20, 2025
Registration
Registered
Classes
005 035 044

Rights Holder

Emergent Operations Ireland Limited

99
Address
6 Earlsfort Terrace, 6th Floor
Dublin 2
IE

Ownership History

Emergent Operations Ireland Limited

Original Applicant
99
Dublin IE

Emergent Operations Ireland Limited

Owner at Publication
99
Dublin IE

Emergent Operations Ireland Limited

Original Registrant
99
Dublin IE

Legal Representation

Attorney
Virginia Wolk Marino

USPTO Deadlines

Next Deadline
1935 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250520)
Due Date
May 20, 2031
Grace Period Ends
November 20, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
May 20, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 20, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 29, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 29, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 7, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 7, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 7, 2025 ALIE A ASSIGNED TO LIE Loading...
Mar 24, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 7, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 7, 2025 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 7, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Feb 6, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 5, 2025 IUAF S USE AMENDMENT FILED Loading...
Feb 5, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 17, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 17, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 14, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 15, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 18, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 14, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 19, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 19, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 28, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 28, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 13, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 13, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 10, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 9, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 25, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations
First Use Anywhere: Sep 23, 2023
First Use in Commerce: Sep 23, 2023
Class 035
Online retail store services featuring opioid antagonists, narcotic antagonists and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose
First Use Anywhere: Sep 23, 2023
First Use in Commerce: Sep 23, 2023
Class 044
Medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists
First Use Anywhere: Aug 23, 2023
First Use in Commerce: Aug 23, 2023

Additional Information

Design Mark
The mark consists of four rectangles all joined to form a half asterisk shape. The white in the drawing represents background and/or transparent areas and is not part of the mark.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 035 044